Search

Conozca las preguntas que debe hacerle a un médico especialista en cáncer pulmonar después de recibir el diagnóstico, de la mano de un especialista de MSK que ha tratado con éxito a muchas personas con cáncer pulmonar.

… Friday, November 1, 2024 Si le han diagnosticado cáncer pulmonar, es importante a dónde acudir en primer lugar. También es importante saber qué preguntas hacerle a su equipo de atención médica. En las últimas dos décadas se han logrado avances notables en la comprensión y el tratamiento del cáncer pulmonar

The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study.

… Friday, March 5, 2021 Summary Pirtobrutinib (also known as LOXO-305), a type of drug called a BTK inhibitor, appears to be effective in many people with blood cancers called B cell malignancies. The incidence of severe side effects for the drug is also very low. The first-ever clinical trial of a new

MSK head and neck surgeons are investigating novel imaging methods that enable them to detect and visualize cancer cells during an operation.

… Thursday, August 17, 2017 Summary Surgery for head and neck cancers is challenging due to the presence of critical nerves and blood vessels near the tumors. MSK surgeons are exploring several new imaging techniques that detect and illuminate cancer cells during the operation. This will enable surgeons

Find out what it’s like to undergo cancer treatment when you work at a cancer hospital like Memorial Sloan Kettering.

… Monday, October 8, 2018 Summary As Director of Case Management at Memorial Sloan Kettering, Laura Ostrowsky oversees discharge planning and follow-up care for people leaving the hospital. She has held the role for 19 years. She was diagnosed with early-stage breast cancer in January 2018 and was treated

Following surgery to remove NF2 tumors in her brain, MSK patient Maggie Chess developed a sudden passion and talent for abstract painting, a rare outcome that has transformed her life.

… Wednesday, July 30, 2025 Maggie Chess holds a special place in her heart for the neurosurgeons at Memorial Sloan Kettering Cancer Center (MSK). Brain surgery at MSK, in 2021, saved Maggie’s life and gave her family much needed hope. But what makes Maggie’s case extraordinary is what she discovered post-surgery

Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.

… Wednesday, December 1, 2021 Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from the Levine Cancer Center in North Carolina and succeeds C. Ola Landgren, MD, PhD, who previously served in this role for six years. Dr. Usmani is

Along with Valentine's Day, February marks American Heart Month. MSK’s Vice Chair of Radiation Oncology, Dr Oren Cahlon talks on how his team are making radiation-induced heart disease “a thing of the past” for our breast cancer patients.

… Tuesday, February 13, 2018

All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery.

… Monday, November 19, 2018 All radiotherapy treatments for prostate cancer should be accompanied by image-guidance of the prostate position to rule out significant setup errors in fractional delivery. The results of our most recent analysis of planning data for 102 patients treated consecutively at Memorial

Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side effects.

… Friday, March 6, 2020 Very low-dose radiotherapy (VLDRT) is effective for treating grade 3A follicular lymphoma and provides patients with a shorter treatment course and fewer side effects. We observed outstanding radiographic responses, local control, and associated palliative benefits in our recent

Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.

… Monday, October 21, 2024 Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists